The convalescent sera option for containing COVID-19

J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
No abstract available

Publication types

  • Historical Article
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Viral / blood
  • Antibodies, Viral / therapeutic use*
  • Betacoronavirus / immunology*
  • Blood Donors
  • Coronavirus Infections / blood
  • Coronavirus Infections / history
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / therapy*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Immunization, Passive / adverse effects
  • Immunization, Passive / history
  • Immunization, Passive / methods
  • Immunization, Passive / standards
  • Pandemics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / therapy*
  • Risk Assessment

Substances

  • Antibodies, Viral

Supplementary concepts

  • COVID-19
  • COVID-19 serotherapy
  • severe acute respiratory syndrome coronavirus 2